Skip to main content
. 2022 Jul 29;9:931207. doi: 10.3389/fcvm.2022.931207

TABLE 7.

Cumulative 30-day and 1-year outcomes.

Overall (N = 155) Severe PPM (N = 10) Moderate PPM (N = 22) None (N = 123) P-value
30-day
CV death 7 (4.5%) 0 (0) 4 (18%) 3 (2.4%) 0.003
All-cause death 11 (7.1%) 1 (10%) 4 (18%) 6 (3.8%) 0.08
Valve related hospitalization 5 (3%) 2 (20%) 0 (0) 3 (2.4%) 0.001
Valve thrombosis 2 (1.3%) 0 (0) 2 (9%) 0 (0) 0.001
NYHA class III-IV 12 (7.7%) 3 (30%) 0 (0) 9 (7.4%) 0.0001
1-year
All-cause death 20 (12.9%) 4 (40%) 4 (18%) 12 (9.7%) 0.016
CV death 9 (5.8%) 2 (20%) 4 (18%) 3 (2.4%) 0.002
Valve related hospitalization 10 (6.5%) 2 (20%) 2 (9%) 6 (5%) 0.15
Valve thrombosis 2 (1.3%) 0 (0) 2 (9%) 0 (0) 0.002
NYHA class III-IV 9 (5.8%) 2 (20%) 0 (0) 7 (5.7%) 0.0001

CV, cardiovascular.